E2 ModerateModerate confidencePEM unclearObservationalPeer-reviewedMachine draft
Surveillance for chronic fatigue syndrome--four U.S. cities, September 1989 through August 1993.
Reyes, M, Gary, H E, Dobbins, J G et al. · MMWR. CDC surveillance summaries : Morbidity and mortality weekly report. CDC surveillance summaries · 1997
Quick Summary
Between 1989 and 1993, researchers in four U.S. cities tracked patients with chronic fatigue syndrome (CFS) to understand how common it was and what it looked like. Of 565 patients evaluated, 130 met the CFS criteria. The study found that CFS affected about 4 to 9 people per 100,000 in the general population, but was much more common in white women. Most CFS patients were in their 30s when they got sick and had been ill for about 7 years.
Why It Matters
This was one of the first systematic, multisite efforts to establish CFS prevalence and clinical characteristics in the United States, providing baseline epidemiologic data that helped establish CFS as a real disease affecting thousands of Americans. The findings highlighted that CFS disproportionately affects white women and has a substantial disease burden, informing public health resource allocation and clinical recognition.
Observed Findings
- Of 565 participating patients, 130 (23%) met 1988 CFS case definition criteria; remaining patients had other diagnoses or unmet criteria.
- CFS patients were predominantly white (96%) and female (85%), with mean age at illness onset of 30 years and mean illness duration of 6.7 years at evaluation.
- Age-, sex-, and race-adjusted 4-year CFS prevalence ranged from 4.0 to 8.7 per 100,000 population across the four cities.
- Among white women specifically, age-adjusted prevalence was substantially higher, ranging from 8.8 to 19.5 per 100,000 population.
- Most CFS patients (96%) had completed high school and 38% had college degrees, with median household income of $40,000.
Inferred Conclusions
- CFS is a measurable public health condition with prevalence estimates of 4–9 cases per 100,000 in the general U.S. population, though substantially higher in white women.
- The demographic pattern of CFS (predominantly affecting women and white populations) was consistent with previously published clinical reports.
- Selection bias and non-representative sampling across the four surveillance sites may have influenced the findings, warranting larger-scale population-based studies.
- The substantial mean illness duration (6.7 years) at evaluation suggests CFS causes prolonged morbidity in affected individuals.
Remaining Questions
What This Study Does Not Prove
This study does not establish the cause of CFS or prove any specific infectious, genetic, or immunologic mechanism. The cross-sectional design cannot determine prognosis, long-term outcomes, or whether the observed demographic patterns reflect true disease distribution or bias in who sought medical care and was referred to the surveillance system.
Tags
Symptom:Cognitive DysfunctionFatigue
Method Flag:Weak Case DefinitionNo ControlsMixed Cohort
Metadata
- PMID
- 12412768
- Review status
- Machine draft
- Evidence level
- Single-study or moderate support from human research
- Last updated
- 8 April 2026
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Spotted an error in this entry? Report it →